Heribert Bieling

TL;DR: Investigating the sensitivity with which ductal carcinoma in situ (DCIS) is diagnosed by mammography and by breast MRI found MRI could help improve the ability to diagnose DCIS, especially DCIS with high nuclear grade.

TL;DR: In this article, the authors investigated the sensitivity with which ductal carcinoma in situ (DCIS) is diagnosed by mammography and by breast MRI and compared the biological profiles of mammography-diagnosed DCIS versus DCIS detected by MRI alone.

TL;DR: An MRI acquisitionTime of 3 minutes and an expert radiologist MIP image reading time of 3 seconds are sufficient to establish the absence of breast cancer, with an NPV of 99.8%.

TL;DR: In this article, the authors defined the range of normal contrast medium enhancement, the variability in contrast medium enhancing patterns in healthy premenopausal breast parenchyma, and the implications for management strategies in cases with incidental contrast medium-enhancing foci on breast magnetic resonance (MR) images.

TL;DR: In women at elevated familial risk, quality-assured MRI screening shifts the distribution of screen-detected breast cancers toward the preinvasive stage and neither mammography, nor annual or half-yearly ultrasound or CBE will add to the cancer yield achieved by MRI alone.